Brunswick, Germany

Wilhem Dirks

This inventor holds 2 USPTO granted patents. Top assignees: Beiersdorf Ag, Gesellschaft Fur Biotechnologische Forschung Mbh, Other. Active years: 1997-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 91(Granted Patents)


Location History:

  • Brunswick, DE (1997)
  • Braunschweig, DE (1999)

Company Filing History:


Years Active: 1997-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wilhem Dirks: Innovator in Pharmaceutical Preparations

Introduction

Wilhem Dirks is a notable inventor based in Brunswick, Delaware. He has made significant contributions to the field of pharmaceuticals, particularly in the production of growth factors.

Latest Patents

Dirks holds 2 patents that focus on innovative methods for producing pharmaceutical preparations. His latest patents include a process for producing a pharmaceutical preparation of PDGF-AB, which involves the recombinant production of PDGF-AB in mammalian cells using a bicistronic vector system. This system features an IRES sequence located between the first and second cistrons, allowing for the equimolar expression of the A and B polypeptide chains. Another patent details the preparation of heterodimeric PDGF-AB using a similar bicistronic vector system.

Career Highlights

Throughout his career, Dirks has worked with various companies, including Beiersdorf AG. His work has contributed to advancements in the pharmaceutical industry, particularly in the development of growth factors.

Collaborations

Dirks has collaborated with notable individuals in his field, including Wolfram Eichner and Albrecht Dorschner. Their combined expertise has furthered the research and development of innovative pharmaceutical solutions.

Conclusion

Wilhem Dirks is a distinguished inventor whose work in pharmaceutical preparations has made a lasting impact. His innovative approaches continue to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…